Private Market View

Tahoe

Drug Discovery · South San Francisco, CA · Founded 2022 · Privately Held (backing)

Last price · $/share
Implied valuation
$131.0M
Total raised
$50.0M
Last round
Early Stage VC (Series A)
Aug 2025
What is Tahoe worth?
$131.0Mlast known valuation

Tahoe last raised $35.0M in its Early Stage VC (Series A) (Aug 2025).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 1 rounds
  • ·The complete investor list — 12 names
  • ·Watchlist + deal alerts for Tahoe
Create free account
No card required

Funding history

1 rounds
DateRoundRaisedPost-money
Aug 2025Early Stage VC (Series A)$35.0M

How Tahoe's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Tahoe, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Tahoe worth?
Tahoe's last known valuation is $131.0M.
How much has Tahoe raised?
Tahoe has raised $50.0M in total funding across 1 recorded rounds.
When did Tahoe last raise?
Tahoe last raised in Aug 2025 (Early Stage VC (Series A)), raising $35.0M.